Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

The new decade of vaccines.

Shann F.

Lancet. 2012 Jan 7;379(9810):26; author reply 27. doi: 10.1016/S0140-6736(12)60016-6. No abstract available.

PMID:
22225662
2.

Health care professional communication about STI vaccines with adolescents and parents.

Hofstetter AM, Rosenthal SL.

Vaccine. 2014 Mar 20;32(14):1616-23. doi: 10.1016/j.vaccine.2013.06.035. Epub 2013 Jun 20. Review.

PMID:
23791695
3.

Microalgal vaccines.

Siripornadulsil S, Dabrowski K, Sayre R.

Adv Exp Med Biol. 2007;616:122-8. Review.

PMID:
18161496
4.

Barriers to the vaccination of children and adolescents and possible solutions.

Esposito S, Principi N, Cornaglia G; ESCMID Vaccine Study Group (EVASG).

Clin Microbiol Infect. 2014 May;20 Suppl 5:25-31. doi: 10.1111/1469-0691.12447. Epub 2014 Jan 24. Review.

5.

[High level of efficacy and safety of antiviral vaccines and unsubstantiated critique].

Gendon IuZ.

Vopr Virusol. 2013 Nov-Dec;58(6):5-13. Review. Russian.

PMID:
24772639
6.

[Criteria for introducing new vaccines into the vaccination calendar].

Ramírez Fernández R, Gutiérrez Rodríguez MA, Sanz Moreno JC.

Rev Esp Quimioter. 2007 Mar;20(1):131-42. Review. Spanish. No abstract available.

7.

Coordinating the delivery of vaccinations and other preventive health care recommendations for adolescents.

Middleman AB.

Prev Med. 2011 Oct;53 Suppl 1:S22-8. doi: 10.1016/j.ypmed.2011.08.016. Review.

PMID:
21962467
8.

Vaccines in pregnancy: a review of their importance in Brazil.

Bricks LF.

Rev Hosp Clin Fac Med Sao Paulo. 2003 Sep-Oct;58(5):263-74. Epub 2003 Nov 11. Review.

9.

Vaccines for travel and international adoption.

Lee PJ.

Pediatr Infect Dis J. 2008 Apr;27(4):351-4. doi: 10.1097/INF.0b013e31816f1368. Review.

PMID:
18379374
10.

Vaccines for the prevention of diseases caused by potential bioweapons.

Hassani M, Patel MC, Pirofski LA.

Clin Immunol. 2004 Apr;111(1):1-15. Review.

PMID:
15093546
11.

[Vaccination and postexposure prophylaxis in heath-care workers].

Gutiérrez MN, Sáenz González MC.

Rev Esp Quimioter. 2009 Dec;22(4):190-200. Review. Spanish.

12.
13.

[Vaccination programs in Poland].

Gładysz A, Rymer W, Inglot M, Rotter K, Knysz B.

Przegl Epidemiol. 2004;58 Suppl 1:80-9. Review. Polish. No abstract available.

PMID:
15807163
14.

Lifelong vaccination as a key disease-prevention strategy.

Bonanni P, Sacco C, Donato R, Capei R.

Clin Microbiol Infect. 2014 May;20 Suppl 5:32-6. Epub 2014 Jan 19. Review.

15.

New vaccines for the national childhood immunisation programme.

Moreton J.

J Fam Health Care. 2004;14(5):114-5. Review. No abstract available.

PMID:
15598007
16.

Technical transformation of biodefense vaccines.

Lu S, Wang S.

Vaccine. 2009 Nov 5;27 Suppl 4:D8-D15. doi: 10.1016/j.vaccine.2009.08.055. Review.

17.

Vaccines for multiple sclerosis: progress to date.

Correale J, Farez M, Gilmore W.

CNS Drugs. 2008;22(3):175-98. Review.

PMID:
18278975
18.

Overview of vaccine field studies: types of effects and designs.

Halloran ME.

J Biopharm Stat. 2006;16(4):415-27. Review.

PMID:
16892904
19.

Assessment of vaccine candidates for persons aged 50 and older: a review.

Eilers R, Krabbe PF, van Essen TG, Suijkerbuijk A, van Lier A, de Melker HE.

BMC Geriatr. 2013 Apr 15;13:32. doi: 10.1186/1471-2318-13-32. Review.

20.

Nicotine vaccines to treat tobacco dependence.

Goniewicz ML, Delijewski M.

Hum Vaccin Immunother. 2013 Jan;9(1):13-25. doi: 10.4161/hv.22060. Epub 2012 Oct 29. Review.

Items per page

Supplemental Content

Write to the Help Desk